Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-18

Clinical Trial Update: Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD

View source ↗

Summary

Clinical trial update describing a pharmacokinetics study comparing whole versus crushed Belumosudil tablets in patients with chronic graft-versus-host disease,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Belumosudil (belumosudil)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Graft Versus Host Disease | Status: RECRUITING